KIMBERLY COONEY: Open Payments
NPI 1558616581 · IRMO, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,864 in 111 payments from 23 companies in 2025. Trend: 2023 $1,107 · 2024 $1,808 · 2025 $1,864
Food & beverage: $1,864
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $242 |
| ABBVIE INC. | 20 | $234 |
| Otsuka America Pharmaceutical, Inc. | 10 | $216 |
| Novo Nordisk Inc | 9 | $174 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $173 |
| Abbott Laboratories | 8 | $120 |
| Dexcom, Inc. | 3 | $113 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| Recor Medical Inc | 3 | $69 |
| Amgen Inc. | 4 | $62 |
Products named: REXULTI, XIFAXAN, AIRSUPRA, Dexcom G6 Transmitter, VRAYLAR, Wegovy, Kerendia, UBRELVY.
Industry payments across SC — which companies pay providers there.
